Total Payments
$5,501
2024 Payments
$499.61
Companies
48
Transactions
301
Medicare Patients
3,876
Medicare Billing
$523,055
Payment Breakdown by Category
Food & Beverage$5,376 (97.7%)
Education$74.99 (1.4%)
Other$50.00 (0.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,376 | 299 | 97.7% |
| Education | $74.99 | 1 | 1.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $50.00 | 1 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $980.01 | 54 | $0 (2024) |
| PFIZER INC. | $504.51 | 24 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $385.53 | 16 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $366.91 | 22 | $0 (2024) |
| Novo Nordisk Inc | $358.24 | 19 | $0 (2023) |
| Astellas Pharma US Inc | $281.85 | 12 | $0 (2021) |
| GlaxoSmithKline, LLC. | $257.97 | 12 | $0 (2023) |
| Amgen Inc. | $166.79 | 9 | $0 (2024) |
| Avanir Pharmaceuticals, Inc. | $160.52 | 11 | $0 (2019) |
| Lilly USA, LLC | $154.28 | 10 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $499.61 | 25 | ABBVIE INC. ($246.83) |
| 2023 | $626.58 | 32 | AbbVie Inc. ($231.81) |
| 2022 | $631.36 | 34 | Bayer HealthCare Pharmaceuticals Inc. ($228.96) |
| 2021 | $962.34 | 48 | AbbVie Inc. ($202.77) |
| 2020 | $285.57 | 18 | Lilly USA, LLC ($45.47) |
| 2019 | $876.44 | 49 | Astellas Pharma US Inc ($139.45) |
| 2018 | $734.11 | 44 | Novo Nordisk Inc ($131.10) |
| 2017 | $885.29 | 51 | PFIZER INC. ($104.61) |
All Payment Transactions
301 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/08/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $15.70 | General |
| Category: Diabetes Care | ||||||
| 10/25/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $29.84 | General |
| Category: NEUROSCIENCE | ||||||
| 10/23/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $19.17 | General |
| Category: Oncology | ||||||
| 09/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.21 | General |
| Category: NEUROSCIENCE | ||||||
| 08/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.56 | General |
| Category: NEUROSCIENCE | ||||||
| 08/22/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $25.34 | General |
| Category: Endocrinology | ||||||
| 08/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.32 | General |
| Category: NEUROSCIENCE | ||||||
| 08/06/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $22.86 | General |
| Category: Respiratory | ||||||
| 07/31/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.97 | General |
| Category: NEUROSCIENCE | ||||||
| 07/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.87 | General |
| Category: NEUROSCIENCE | ||||||
| 06/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.59 | General |
| Category: NEUROSCIENCE | ||||||
| 05/17/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: Endocrinology | ||||||
| 05/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $29.78 | General |
| Category: NEUROSCIENCE | ||||||
| 05/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $2.45 | General |
| Category: NEUROSCIENCE | ||||||
| 04/22/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: Respiratory | ||||||
| 04/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.03 | General |
| Category: NEUROSCIENCE | ||||||
| 04/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $28.66 | General |
| Category: NEUROSCIENCE | ||||||
| 03/21/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.57 | General |
| Category: Respiratory | ||||||
| 03/15/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $28.52 | General |
| Category: Inflammation | ||||||
| 03/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.44 | General |
| Category: NEUROSCIENCE | ||||||
| 02/28/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | CYLTEZO (Biological) | Food and Beverage | In-kind items and services | $32.79 | General |
| Category: CNS | ||||||
| 02/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.29 | General |
| Category: NEUROSCIENCE | ||||||
| 01/31/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: PAIN | ||||||
| 01/30/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $38.15 | General |
| Category: VACCINES | ||||||
| 01/10/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $11.82 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 951 | 2,106 | $252,270 | $134,681 |
| 2022 | 16 | 958 | 2,250 | $258,989 | $142,162 |
| 2021 | 18 | 999 | 2,174 | $232,545 | $138,878 |
| 2020 | 19 | 968 | 2,028 | $213,240 | $107,335 |
Total Patients
3,876
Total Services
8,558
Medicare Billing
$523,055
Procedure Codes
67
All Medicare Procedures & Services
67 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 177 | 558 | $97,650 | $51,734 | 53.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 91 | 234 | $52,650 | $32,556 | 61.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 108 | 372 | $48,360 | $24,970 | 51.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 28 | 148 | $15,540 | $9,784 | 63.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 30 | 42 | $9,030 | $4,592 | 50.9% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 32 | 45 | $6,075 | $3,029 | 49.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 158 | 271 | $5,420 | $2,238 | 41.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 53 | 53 | $1,590 | $1,558 | 98.0% |
| 99421 | Online digital evaluation and management service for an established patient for up to 7 days, total time 5-10 minutes | Office | 2023 | 76 | 116 | $4,640 | $1,241 | 26.7% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 53 | 53 | $3,180 | $1,159 | 36.4% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 22 | 26 | $2,730 | $931.73 | 34.1% |
| 81002 | Urinalysis, manual test | Office | 2023 | 76 | 133 | $1,995 | $458.52 | 23.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 32 | 33 | $2,970 | $377.27 | 12.7% |
| 85018 | Blood count, hemoglobin | Office | 2023 | 15 | 22 | $440.00 | $51.04 | 11.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 175 | 701 | $120,845 | $70,234 | 58.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 117 | 412 | $52,515 | $28,951 | 55.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 81 | 165 | $37,230 | $22,892 | 61.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 25 | 126 | $13,280 | $7,500 | 56.5% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 20 | 28 | $6,020 | $3,079 | 51.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 68 | 68 | $2,040 | $1,999 | 98.0% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 24 | 33 | $4,455 | $1,987 | 44.6% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2022 | 68 | 68 | $4,080 | $1,434 | 35.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 168 | 339 | $6,780 | $1,005 | 14.8% |
| 99421 | Online digital evaluation and management service for an established patient for up to 7 days, total time 5-10 minutes | Office | 2022 | 67 | 95 | $3,360 | $943.67 | 28.1% |
| 69210 | Removal of impacted ear wax | Office | 2022 | 19 | 24 | $2,520 | $920.19 | 36.5% |
About Dr. Gail Bryant, MD
Dr. Gail Bryant, MD is a Family Medicine healthcare provider based in Arlington Hts, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1447202064.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gail Bryant, MD has received a total of $5,501 in payments from pharmaceutical and medical device companies, with $499.61 received in 2024. These payments were reported across 301 transactions from 48 companies. The most common payment nature is "Food and Beverage" ($5,376).
As a Medicare-enrolled provider, Bryant has provided services to 3,876 Medicare beneficiaries, totaling 8,558 services with total Medicare billing of $523,055. Data is available for 4 years (2020–2023), covering 67 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Arlington Hts, IL
- Active Since 05/16/2006
- Last Updated 04/29/2011
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1447202064
Products in Payments
- VRAYLAR (Drug) $523.27
- Kerendia (Drug) $385.53
- ELIQUIS (Drug) $255.60
- TRELEGY ELLIPTA (Drug) $244.86
- Ozempic (Drug) $230.44
- FARXIGA (Drug) $162.20
- LYRICA (Drug) $146.25
- Otezla (Drug) $143.14
- MYRBETRIQ (Drug) $139.27
- CHANTIX (Drug) $138.05
- Humira (Biological) $134.88
- UBRELVY (Drug) $129.64
- NUEDEXTA (Drug) $110.43
- TRULICITY (Drug) $101.75
- Synthroid (Drug) $89.85
- MOVANTIK (Drug) $76.83
- ONZETRA XSAIL (Drug) $73.03
- CONTRAVE (Drug) $72.33
- XIFAXAN (Drug) $70.11
- PRALUENT (Drug) $69.44
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.